scispace - formally typeset
D

Dana P. Goldman

Researcher at University of Southern California

Publications -  381
Citations -  16877

Dana P. Goldman is an academic researcher from University of Southern California. The author has contributed to research in topics: Health care & Population. The author has an hindex of 62, co-authored 377 publications receiving 15247 citations. Previous affiliations of Dana P. Goldman include George Washington University & Dana Corporation.

Papers
More filters
Journal ArticleDOI

The effect of regulation on pharmaceutical revenues: experience in nineteen countries.

TL;DR: It is shown that the cost-reducing effects of price controls increase the longer they remain in place and that new regulations in a largely unregulated market, such as the United States, could greatly reduce pharmaceutical revenues.
Journal ArticleDOI

Undiagnosed Disease, Especially Diabetes, Casts Doubt on Some of Reported Health 'Advantage' of Recent Mexican Immigrants

TL;DR: It is found that Mexican immigrants are not as healthy as previously thought when undiagnosed disease is taken into account, particularly with respect to diabetes, and medical practice should emphasize disease detection among new arrivals as part of routine visits.
Journal ArticleDOI

Toward a 21st-century health care system: Recommendations for health care reform

Kenneth J. Arrow, +49 more
TL;DR: The FRESH-Thinking project convenes a multidisciplinary group of scholars who collaborate to comprehensively study the specific, detailed challenges to health care reform, finding common ground on 8 fundamental policy recommendations to achieve needed fundamental reforms.
Journal ArticleDOI

Aligning incentives to fulfil the promise of personalised medicine

TL;DR: An existing health simulation model is used to consider the benefi ts (and costs) of PPM innovations to improve screening and risk-factor stratifi cation technologies that identify presymptomatic individuals at high risk of specifi c diseases.
Journal ArticleDOI

Economic Burden of Undiagnosed Nonvalvular Atrial Fibrillation in the United States

TL;DR: In this article, the authors estimated the United States (US) incremental cost burden of undiagnosed nonvalvular atrial fibrillation (AF) nationally using administrative claims data.